Sionna Therapeutics Upgraded by Royal Bank Of Canada

Shares of Sionna Therapeutics (NASDAQ:SION) have received a boost from Royal Bank Of Canada, which upgraded its rating to 'Sector Perform' in a report issued on Monday.

The firm's target price for the stock is $5.00, representing a potential upside of 23.30% from its current price.

This upgrade comes as part of a broader trend, with several other research firms also weighing in on SION. Raymond James Financial has reiterated a 'strong-buy' rating and issued a $59.00 price target, while Guggenheim upped its target price to $60.00 and gave the company a 'buy' rating.

However, not all analysts are as bullish, with Wedbush reissuing a 'neutral' rating and setting a $5.00 price target, and Stifel Nicolaus reaffirming a 'hold' rating and setting a $7.00 price objective.